Objective. The aim of this study was to assess the efficacy of anti-TNF-α therapy in refractory
uveitis due to Behçet's disease (BD). Methods. We performed a multicentre study of 124 …

Objective. To assess the efficacy of other biologic therapies, different from IFX and ADA, in
patients with Behçet's disease uveitis (BU). Methods. Multicentre study of 124 patients with …

Objective. Behçet's disease (BD) is a chronic multisystem inflammatory disorder associated
to uveitis that may represent a serious sight-threatening condition. The purpose of the …

Objective To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first‐line
biologic drug over 1 year of treatment in a large series of patients with refractory uveitis due …

Purpose: To assess long-term efficacy and safety of infliximab for refractory Behçet disease
(BD) uveitis and to evaluate the effect of withdrawal of infliximab after achieving long-term …

Purpose To evaluate the long-term safety and efficacy of infliximab therapy for refractory
uveitis associated with Behçet's disease (BD). Methods We prospectively enrolled six …

In this open-label trial, ten male patients with active Behcet's uveitis were enrolled. Initially,
two infliximab infusions (5 mg/kg) were given at weeks 0 and 2. The patients continued to …

Objective To assess the efficacy of tocilizumab (TCZ) in refractory uveitis of Behçet's disease
(BD). Methods Multicentre study of patients with BD-associated uveitis. Patients were …

Purpose To evaluate the long-term efficacy and safety of infliximab for the treatment of
uveitis in Behçet's disease (BD). Design Retrospective multicenter study using a …

Behcet's disease (BD) is a chronic, relapsing, multisystem disease. In some patients, ocular
involvement can lead to severe vision impairment despite immunosuppressive therapy …